In the article “Amyloid Imaging Update: How the Amyloid Landscape Is Changing in Light of the Recent Food and Drug Administration Approval of Antiamyloid Therapeutics,” by Grabher (J Nucl Med Technol. 2024;52:314–325), the author affiliation was updated to Grabher Consulting & Specialty Services [not Life Molecular Imaging]; the correspondence e-mail was updated to barbara.grabher{at}gmail.com [not b.grabher{at}life-mi.com]; and the disclosure was updated to “Barbara Grabher is a full-time employee of Life Molecular Imaging as a Clinical Applications Specialist, supporting their amyloid imaging tracer, Neuraceq. Her affiliation does not endorse one specific tracer over another.” These have been corrected online. The author regrets the errors.
In the article “SNMMI-TS Nuclear Medicine Technology Universal AES/CI Handbook,” by Johnson et al. (J Nucl Med Technol. 2024;52:285–298), Jane Kamm of SNMMI should not have been listed as a coauthor. The error has been corrected in the online article. We regret the error.
